Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Øyelege Akil AS
AS
Active
Org 998142067
Piggsoppveien 20A, 2016
Frogner
Medical specialists activities
·
NACE 8622
Est. 2012 · 14 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Medical specialists activities
/
Øyelege Akil AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
9M
7M
4M
2M
0M
2020: 6M
6M
2020
2021: 7M (+17% vs 2020)
7M
+17%
2021
2022: 7M (0% vs 2021)
7M
0%
2022
2023: 7M (0% vs 2022)
7M
0%
2023
2024: 7M (0% vs 2023)
7M
0%
2024
EBITDA
NOK millions
5M
3M
0M
-2M
-4M
2020: 2M
2M
2020
2021: 3M (+50% vs 2020)
3M
+50%
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: -2M (-167% vs 2022)
-2M
-167%
2023
2024: 2M (+200% vs 2023)
2M
+200%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
7 412
7 226
6 556
6 793
5 725
Staff expenses
−1 801
−1 564
−1 418
−1 412
−1 415
EBITDA
2 119
−1 881
2 842
2 908
2 256
Depreciation & amort.
−10
−12
−4
−0
−0
EBIT
2 110
−1 893
2 838
2 908
2 256
Net financials
162
−9
−1 343
974
−80
Profit before tax
2 272
−1 902
1 495
3 883
2 176
Tax
500
−429
615
625
479
Net profit
1 772
−1 473
881
3 257
1 697
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
21 728
18 033
19 542
19 234
19 694
Equity
15 203
13 431
14 904
14 024
10 767
Long-term debt
5 156
2 663
2 235
3 237
4 233
Short-term debt
1 369
1 939
2 402
1 974
4 694
Total debt
6 525
4 602
4 637
5 210
8 927
Financial ratios
5-year trend
EBITDA margin
28,6 %
This company
15,8 %
Market median
This company
Market median
81% above market
2020
2024
Equity ratio
70,0 %
This company
38,2 %
Market median
This company
Market median
83% above market
2020
2024
Return on equity
11,7 %
This company
18,4 %
Market median
This company
Market median
36% below market
2020
2024
Net profit margin
23,9 %
This company
8,1 %
Market median
This company
Market median
195% above market
2020
2024
Asset turnover
0,34×
This company
1,12×
Market median
This company
Market median
70% below market
2020
2024
Debt / equity
0,43×
This company
0,62×
Market median
This company
Market median
31% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Øyelege Akil AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
